IMPORTANCE: Although schizophrenia is characterized by impairments in intelligence and the loss of brain volume, the relationship between changes in IQ and brain measures is not clear. OBJECTIVE: To investigate the association between IQ and brain measures in patients with schizophrenia across time. DESIGN, SETTING, AND PARTICIPANTS: Case-control longitudinal study at the Department of Psychiatry at the University Medical Center Utrecht, Utrecht, the Netherlands, comparing patients with schizophrenia and healthy control participants between September 22, 2004, and April 17, 2008. Magnetic resonance imaging of the brain and IQ scores were obtained at baseline and the 3-year follow-up. Participants included 84 patients with schizophrenia (mean illness duration, 4.35 years) and 116 age-matched healthy control participants. MAIN OUTCOMES AND MEASURES: Associations between changes in IQ and the total brain, cerebral gray matter, cerebral white matter, lateral ventricular, third ventricles, cortical, and subcortical volumes; cortical thickness; and cortical surface area. RESULTS: Cerebral gray matter volume (P = .006) and cortical volume (P = .03) and thickness (P = .02) decreased more in patients with schizophrenia across time compared with control participants. Patients showed additional loss in cortical volume and thickness of the right supramarginal, posterior superior temporal, left supramarginal, left postcentral, and occipital regions (P values were between <.001 and .03 after clusterwise correction). Although IQ increased similarly in patients with schizophrenia and control participants, changes in IQ were negatively correlated with changes in lateral ventricular volume (P = .05) and positively correlated with changes in cortical volume (P = .007) and thickness (P = .004) only in patients with schizophrenia. Positive correlations between changes in IQ and cortical volume and thickness were found globally and in widespread regions across frontal, temporal, and parietal cortices (P values were between <.001 and .03 after clusterwise correction). These findings were independent of symptom severity at follow-up, cannabis use, and the use of cumulative antipsychotic medications during the 3 years of follow-up. CONCLUSIONS AND RELEVANCE: Progressive brain tissue loss in schizophrenia is related to relative cognitive decline during the early course of illness.
IMPORTANCE: Although schizophrenia is characterized by impairments in intelligence and the loss of brain volume, the relationship between changes in IQ and brain measures is not clear. OBJECTIVE: To investigate the association between IQ and brain measures in patients with schizophrenia across time. DESIGN, SETTING, AND PARTICIPANTS: Case-control longitudinal study at the Department of Psychiatry at the University Medical Center Utrecht, Utrecht, the Netherlands, comparing patients with schizophrenia and healthy control participants between September 22, 2004, and April 17, 2008. Magnetic resonance imaging of the brain and IQ scores were obtained at baseline and the 3-year follow-up. Participants included 84 patients with schizophrenia (mean illness duration, 4.35 years) and 116 age-matched healthy control participants. MAIN OUTCOMES AND MEASURES: Associations between changes in IQ and the total brain, cerebral gray matter, cerebral white matter, lateral ventricular, third ventricles, cortical, and subcortical volumes; cortical thickness; and cortical surface area. RESULTS: Cerebral gray matter volume (P = .006) and cortical volume (P = .03) and thickness (P = .02) decreased more in patients with schizophrenia across time compared with control participants. Patients showed additional loss in cortical volume and thickness of the right supramarginal, posterior superior temporal, left supramarginal, left postcentral, and occipital regions (P values were between <.001 and .03 after clusterwise correction). Although IQ increased similarly in patients with schizophrenia and control participants, changes in IQ were negatively correlated with changes in lateral ventricular volume (P = .05) and positively correlated with changes in cortical volume (P = .007) and thickness (P = .004) only in patients with schizophrenia. Positive correlations between changes in IQ and cortical volume and thickness were found globally and in widespread regions across frontal, temporal, and parietal cortices (P values were between <.001 and .03 after clusterwise correction). These findings were independent of symptom severity at follow-up, cannabis use, and the use of cumulative antipsychotic medications during the 3 years of follow-up. CONCLUSIONS AND RELEVANCE: Progressive brain tissue loss in schizophrenia is related to relative cognitive decline during the early course of illness.
Authors: Sean A P Clouston; Katherine Jonas; Laura J Fochtmann; Evelyn J Bromet; Roman Kotov Journal: J Gerontol A Biol Sci Med Sci Date: 2020-06-18 Impact factor: 6.053
Authors: Olav B Smeland; Yunpeng Wang; Oleksandr Frei; Wen Li; Derrek P Hibar; Barbara Franke; Francesco Bettella; Aree Witoelar; Srdjan Djurovic; Chi-Hua Chen; Paul M Thompson; Anders M Dale; Ole A Andreassen Journal: Schizophr Bull Date: 2018-06-06 Impact factor: 9.306
Authors: Donald C Goff; Botao Zeng; Babak A Ardekani; Erica D Diminich; Yingying Tang; Xiaoduo Fan; Isaac Galatzer-Levy; Chenxiang Li; Andrea B Troxel; Jijun Wang Journal: JAMA Psychiatry Date: 2018-04-01 Impact factor: 21.596
Authors: Veronica A Murphy; Mark D Shen; Sun Hyung Kim; Emil Cornea; Martin Styner; John H Gilmore Journal: Biol Psychiatry Cogn Neurosci Neuroimaging Date: 2020-04-01
Authors: Tara A Niendam; Kimberly L Ray; Ana-Maria Iosif; Tyler A Lesh; Stefania R Ashby; Pooja K Patel; Jason Smucny; Emilio Ferrer; Marjorie Solomon; J Daniel Ragland; Cameron S Carter Journal: JAMA Psychiatry Date: 2018-12-01 Impact factor: 21.596
Authors: Joost Janssen; Covadonga M Díaz-Caneja; Clara Alloza; Anouck Schippers; Lucía de Hoyos; Javier Santonja; Pedro M Gordaliza; Elizabeth E L Buimer; Neeltje E M van Haren; Wiepke Cahn; Celso Arango; René S Kahn; Hilleke E Hulshoff Pol; Hugo G Schnack Journal: Schizophr Bull Date: 2021-03-16 Impact factor: 9.306
Authors: Tamsyn E Van Rheenen; Vanessa Cropley; Andrew Zalesky; Chad Bousman; Ruth Wells; Jason Bruggemann; Suresh Sundram; Danielle Weinberg; Roshel K Lenroot; Avril Pereira; Cynthia Shannon Weickert; Thomas W Weickert; Christos Pantelis Journal: Schizophr Bull Date: 2018-04-06 Impact factor: 9.306